Cargando…
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study
OBJECTIVE: To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. DESIGN: Seroprevalence cross-sectional study. SETTING: Single centre at the end of the first COVID-19 wave in Lausa...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260307/ https://www.ncbi.nlm.nih.gov/pubmed/34226231 http://dx.doi.org/10.1136/bmjopen-2021-049232 |
_version_ | 1783718793623633920 |
---|---|
author | Meylan, Sylvain Dafni, Urania Lamoth, Frederic Tsourti, Zoi Lobritz, Michael A Regina, Jean Bressin, Philippe Senn, Laurence Grandbastien, Bruno Andre, Cyril Fenwick, Craig D'Acremont, Valerie Croxatto, Antony Guilleret, Isabelle Greub, Gilbert Manuel, Oriol Calandra, Thierry Pantaleo, Giuseppe Lazor-Blanchet, Catherine |
author_facet | Meylan, Sylvain Dafni, Urania Lamoth, Frederic Tsourti, Zoi Lobritz, Michael A Regina, Jean Bressin, Philippe Senn, Laurence Grandbastien, Bruno Andre, Cyril Fenwick, Craig D'Acremont, Valerie Croxatto, Antony Guilleret, Isabelle Greub, Gilbert Manuel, Oriol Calandra, Thierry Pantaleo, Giuseppe Lazor-Blanchet, Catherine |
author_sort | Meylan, Sylvain |
collection | PubMed |
description | OBJECTIVE: To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. DESIGN: Seroprevalence cross-sectional study. SETTING: Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. PARTICIPANTS: 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. MAIN OUTCOME MEASURES: Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisition risk factors internal and external to the workplace. RESULTS: The overall SARS-CoV-2 seroprevalence rate among HCWs was 10.0% (95% CI 8.7% to 11.5%). HCWs with daily patient contact did not experience increased rates of seropositivity relative to those without (10.3% vs 9.6%, respectively, p=0.64). HCWs with direct contact with patients with COVID-19 or working in COVID-19 units did not experience increased seropositivity rates relative to their counterparts (10.4% vs 9.8%, p=0.69 and 10.6% vs 9.9%, p=0.69, respectively). However, specific locations of contact with patients irrespective of COVID-19 status—in patient rooms or reception areas—did correlate with increased rates of seropositivity (11.9% vs 7.5%, p=0.019 and 14.3% vs 9.2%, p=0.025, respectively). In contrast, HCWs with a suspected or proven SARS-CoV-2-infected household contact had significantly higher seropositivity rates than those without such contacts (19.0% vs 8.7%, p<0.001 and 42.1% vs 9.4%, p<0.001, respectively). Finally, consistent use of a mask on public transportation correlated with decreased seroprevalence (5.3% for mask users vs 11.2% for intermittent or no mask use, p=0.030). CONCLUSIONS: The overall seroprevalence was 10% without significant differences in seroprevalence between HCWs exposed to patients with COVID-19 and HCWs not exposed. This suggests that, once fully in place, protective measures limited SARS-CoV-2 occupational acquisition within the hospital environment. SARS-CoV-2 seroconversion among HCWs was associated primarily with community risk factors, particularly household transmission. |
format | Online Article Text |
id | pubmed-8260307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82603072021-07-09 SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study Meylan, Sylvain Dafni, Urania Lamoth, Frederic Tsourti, Zoi Lobritz, Michael A Regina, Jean Bressin, Philippe Senn, Laurence Grandbastien, Bruno Andre, Cyril Fenwick, Craig D'Acremont, Valerie Croxatto, Antony Guilleret, Isabelle Greub, Gilbert Manuel, Oriol Calandra, Thierry Pantaleo, Giuseppe Lazor-Blanchet, Catherine BMJ Open Infectious Diseases OBJECTIVE: To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure. DESIGN: Seroprevalence cross-sectional study. SETTING: Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland. PARTICIPANTS: 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs. MAIN OUTCOME MEASURES: Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisition risk factors internal and external to the workplace. RESULTS: The overall SARS-CoV-2 seroprevalence rate among HCWs was 10.0% (95% CI 8.7% to 11.5%). HCWs with daily patient contact did not experience increased rates of seropositivity relative to those without (10.3% vs 9.6%, respectively, p=0.64). HCWs with direct contact with patients with COVID-19 or working in COVID-19 units did not experience increased seropositivity rates relative to their counterparts (10.4% vs 9.8%, p=0.69 and 10.6% vs 9.9%, p=0.69, respectively). However, specific locations of contact with patients irrespective of COVID-19 status—in patient rooms or reception areas—did correlate with increased rates of seropositivity (11.9% vs 7.5%, p=0.019 and 14.3% vs 9.2%, p=0.025, respectively). In contrast, HCWs with a suspected or proven SARS-CoV-2-infected household contact had significantly higher seropositivity rates than those without such contacts (19.0% vs 8.7%, p<0.001 and 42.1% vs 9.4%, p<0.001, respectively). Finally, consistent use of a mask on public transportation correlated with decreased seroprevalence (5.3% for mask users vs 11.2% for intermittent or no mask use, p=0.030). CONCLUSIONS: The overall seroprevalence was 10% without significant differences in seroprevalence between HCWs exposed to patients with COVID-19 and HCWs not exposed. This suggests that, once fully in place, protective measures limited SARS-CoV-2 occupational acquisition within the hospital environment. SARS-CoV-2 seroconversion among HCWs was associated primarily with community risk factors, particularly household transmission. BMJ Publishing Group 2021-07-05 /pmc/articles/PMC8260307/ /pubmed/34226231 http://dx.doi.org/10.1136/bmjopen-2021-049232 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Infectious Diseases Meylan, Sylvain Dafni, Urania Lamoth, Frederic Tsourti, Zoi Lobritz, Michael A Regina, Jean Bressin, Philippe Senn, Laurence Grandbastien, Bruno Andre, Cyril Fenwick, Craig D'Acremont, Valerie Croxatto, Antony Guilleret, Isabelle Greub, Gilbert Manuel, Oriol Calandra, Thierry Pantaleo, Giuseppe Lazor-Blanchet, Catherine SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study |
title | SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study |
title_full | SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study |
title_fullStr | SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study |
title_full_unstemmed | SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study |
title_short | SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study |
title_sort | sars-cov-2 seroprevalence in healthcare workers of a swiss tertiary care centre at the end of the first wave: a cross-sectional study |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260307/ https://www.ncbi.nlm.nih.gov/pubmed/34226231 http://dx.doi.org/10.1136/bmjopen-2021-049232 |
work_keys_str_mv | AT meylansylvain sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT dafniurania sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT lamothfrederic sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT tsourtizoi sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT lobritzmichaela sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT reginajean sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT bressinphilippe sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT sennlaurence sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT grandbastienbruno sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT andrecyril sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT fenwickcraig sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT dacremontvalerie sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT croxattoantony sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT guilleretisabelle sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT greubgilbert sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT manueloriol sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT calandrathierry sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT pantaleogiuseppe sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT lazorblanchetcatherine sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy AT sarscov2seroprevalenceinhealthcareworkersofaswisstertiarycarecentreattheendofthefirstwaveacrosssectionalstudy |